Surgery, Gastroenterology and Oncology
Vol. 20, No. 3, September 2015
A new score to predict outcome after liver transplantation
Speranţa Iacob, Liana Gheorghe, Daniela Tabacelia, Razvan Iacob, Cristian Gheorghe, Irinel Popescu
ORIGINAL PAPER, September 2015
Article DOI: 10.21614/jtmr-20-3-43
Read article Background: An ideal liver allocation system should reduce waitlist mortality and also improve post-transplant survival.

Aim: To identify a new scoring system that predicts recipient survival at 3 months following liver transplantation (LT) in the Romanian program.

Methods: We included into analysis 242 adult patients (183 patients within the training set and 59 in the validation cohort) with liver cirrhosis consecutively transplanted between January 2012 and June 2014.

Results: Post-transplant overall survival was 84.2% at 3 months....[more]
Circulating miR-21 and TGF-b1 expression levels in patients with cardiovascular diseases
Irina Huica, Iulia V. Iancu, Anca Botezatu, Otilia Banu, Elena Lupeanu, Mariana Anton
ORIGINAL PAPER, September 2015
Article DOI: 10.21614/jtmr-20-3-44
Read article Recent works focus on the role microRNAs (miRNAs) play in regulation of cardiovascular pathology. One of the miRNAs highly expressed in cardiovascular system is miR-21. The aim of this study was to investigate the relationship between the expression level of miR-21 in cardiac disease and correlate with TGF-b1, one of its targets.

Methods: Plasma samples from patients with CVD (cardiovascular diseases) established according to clinical and paraclinical exams were subjected to total RNAs isolation. miR-21 expression levels in patients with CVD and in healthy control subje....[more]
Ureteral access sheath during retrograde flexible uretero-renoscopy: safe tool or safety hazard?
Răzvan Mulţescu, Bogdan Geavlete, Răzvan Satalan, Dragoş Georgescu, Petrişor Geavlete
ORIGINAL PAPER, September 2015
Article DOI: 10.21614/jtmr-20-3-45
Read article Objectives: To evaluate the morbidity of ureteral access sheath (UAS) use during retrograde flexible ureteroscopy, and after a minimum follow-up period of 18 months.

Methodology: We prospectively evaluated 237 patients treated by retrograde flexible ureteroscopic approach for single pyelocaliceal stones: 126 in which a 10 12F UAS was used were compared with 111 in which the procedure was performed without it. Patients were followed for at least 18 months. 15% of the first group and 12.6% of the second one were JJ stented preoperatively. UAS related ureteral wall....[more]
Predictive biomarkers for chemotherapies in pancreatic cancer
Augustin Catalin Dima, Alina Dima, Sever Calin Moldovan, Mircea Ciurea
REVIEW, September 2015
Article DOI: 10.21614/jtmr-20-3-46
Read article Pancreatic cancer is associated with high rates of mortality especially due to advanced stages of diagnosis. Adjuvant chemotherapy role is thus essential in the attempt to downstage the tumoral grade. In cases of locally advanced tumors, this step could be followed by curative surgical resection.
Characterization of predictor biomarkers for adjuvant chemotherapy has drawn increasing interest in molecular biology research of pancreatic cancer. Personalized treatment is one of the solutions proposed for advancing towards a better outcome. In this paper we discuss available predicto....[more]
CA 125 in biological fluids
Alexandra Gireadă, Irina Bălescu, Nicolae Bacalbaşa
REVIEW, September 2015
Article DOI: 10.21614/jtmr-20-3-47
Read article CA 125 is one of the most popular tumor markers usually synthetized by normal and malignant cells of different origins.
Increased levels can be found in both benign and malignant conditions in fluids with different origins such as pleural effusion, ascites, ovarian cysts fluids, amniotic fluid and even pancreatic cyst fluids. This is a literature review of the largest studies regarding various conditions in which increased levels of CA 125 can be found and their clinical significance.

Keywords: CA 125, amniotic fluid, cyst fluid, ascites, pleural effusion
Central pancreatectomy for a pancreatic metastasis of colon cancer - a case report
Traian Dumitraşcu, Andra Scarlat, Silviu Ciurea, Irinel Popescu
CASE REPORT, September 2015
Article DOI: 10.21614/jtmr-20-3-48
Read article Background: Isolated pancreatic metastases of other neoplasms are an uncommon pathology, particularly with a colo-rectal cancer origin. Surgery represents the single hope for a long-term survival in these patients, but most of the previously reported patients in the literature underwent standard pancreatic resections.
A central pancreatectomy is a non-standardized pancreatic resection, which was exceptionally reported for a malignant pathology.

Case presentation: A 30-years old male, with previously left hemicolectomy for a sigmoid colon adenocarcinoma and l....[more]
Severe vasculo-biliary injury (D4dpv) following laparoscopic cholecystectomy: case report
Ivelin Takorov, Ts. Lukanova, I. Vasilevski, V. Mihaylov, A. Hartova, E. Odisseeva, N. Vladov
CASE REPORT, September 2015
Article DOI: 10.21614/jtmr-20-3-49
Read article Introduction: Combined vasculo-biliary injuries, including biliary duct, hepatic artery and portal vein, arevery rare, but severe complicationsafter cholecystectomy due to their high morbidity and mortality.

Case presentation: We present a D4dpv (according to Hanover-classification of biliary injuries) biliary tract injury in a 41-years-old lady who underwent an elective laparoscopic cholecystectomy with a conversion for a massive bleeding from portal vein. Total transection of the common hepatic duct, sutured portal vein, narrowed up to 25 % at the near trifurc....[more]
Multiparametric MRI diagnostic value in a case of prostate cancer
Gelu Adrian Popa, Ioana Gabriela Lupescu, Emi M. Preda, Cristina Nicolae, Anca Filip Flintoaca, Răzvan Alexandru Capşa, C. Scheau, A. Dijmarescu, Mihaela Mihai, A. Preda
CASE REPORT, September 2015
Article DOI: 10.21614/jtmr-20-3-50
Read article Prostate cancer (PC) is one of the most prevalent malignant tumour in men, especially in elderly patients. The aim of this paper is to present and illustrate the utility of multiparametric (MP) MRI in the diagnostic of PC. A 66 years old patient with clincal suspicion of PC was explored by MP MRI.
The MR examination included T2-wi, dynamic contrast-enhanced (DCE) MRI and diffusion-weighted imaging (DWI) acquisitions.
The final MR diagnosis was prostate tumor with the TNM-stage T4 N1 Mx. Radical prostatectomy revealed a Gleason score 7 (4+3) adenocarcinoma with extraprostatic ....[more]
Neonatal Graves-Basedow disease due to long-standing TRAb persistence following total thyroidectomy
Emiliana Teodora Dragomir-Ananie, Camelia Procopiuc, Florea Caliopsia, Maricica Gusa, Carmen Cristina Diaconu
CASE REPORT, September 2015
Article DOI: 10.21614/jtmr-20-3-51
Read article Background: Neonatal Graves-Basedow disease is a rare and transient complication due to mother's Basedow disease, occurring extremely rare due to Hashimoto thyroiditis or as a persistent hyperthyroidism due to activating mutations of the Thyroid-Stimulating Hormone (TSH) receptor. It may cause goiter and hyperthyroidism in the neonate, prematurity or fetal death, in some cases needing therapy and pre-conception counseling.

Case presentation: We report the case of a premature newborn from a mother who underwent total thyroidectomy for Basedow disease 7 years befo....[more]
Tumoral pericardial involvement in non-Hodgkin lymphoma-spektrum of CT findings
Anca Filip Flintoaca, Magdalena Ichim, Dana Tabac, Ioana Gabriela Lupescu
CASE REPORT, September 2015
Article DOI: 10.21614/jtmr-20-3-52
Read article Lymphomatous involvement of pericardium is relatively commonly seen in patients diagnosed with Hodking and non-Hodgking disease, presenting large mediastinal mass.
Pericardial and cardiac involvement may be a late manifestation of lymphoma. Pericardial nodular thickening or effusion, a tumoral mass extending into the superior pulmonary veins are signs of secondary tumoral pericardial involvement. But pericardial effusion is not a specific and reliable sign of tumoral pericardium, because in patient with lymphoma can be seen postradiotherapy or in case of infection.
Familiarit....[more]
Radical surgical approach for synchronous ovarian and uterine cervix tumor with uterine cervix liver metastasis
Nicolae Bacalbaşa, Irina Bălescu
CASE REPORT, September 2015
Article DOI: 10.21614/jtmr-20-3-53
Read article Synchronous ovarian and uterine cervix malignancies are extremely rare gynecologic neoplasia. In the meantime the presence of hepatic metastases originating from cervical cancer is another rare situation, the liver being more often a common site of metastases for ovarian malignancies.
We present the case of a 63-year-old patient who was diagnosed with a moderately differentiated squamous cell cervical tumor with urinary bladder invasion associated with an ovarian tumorand liver metastases. An anterior exenteration and atypical liver resection were performed; the histopathological....[more]

Watch Video Articles


For Authors



Journal Subscriptions

Current Issue

Sept 2024

Supplements

Instructions for authors
Online submission
Contact
ISSN: 2559 - 723X (print)

e-ISSN: 2601 - 1700 (online)

ISSN-L: 2559 - 723X

Journal Abbreviation: Surg. Gastroenterol. Oncol.

Surgery, Gastroenterology and Oncology (SGO) is indexed in:
  • SCOPUS
  • EBSCO
  • DOI/Crossref
  • Google Scholar
  • SCImago
  • Harvard Library
  • Open Academic Journals Index (OAJI)

Open Access Statement

Surgery, Gastroenterology and Oncology (SGO) is an open-access, peer-reviewed online journal published by Celsius Publishing House. The journal allows readers to read, download, copy, distribute, print, search, or link to the full text of its articles.

Journal Metrics

Time to first editorial decision: 25 days
Rejection rate: 61%
CiteScore: 0.2



Meetings and Courses in 2025
Meetings and Courses in 2024
Meetings and Courses in 2023
Meetings and Courses in 2022
Meetings and Courses in 2021
Meetings and Courses in 2020
Meetings and Courses in 2019
Verona expert meeting 2019

Creative Commons License
Surgery, Gastroenterology and Oncology applies the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits readers to copy and redistribute the material in any medium or format, remix, adapt, build upon the published works non-commercially, and license the derivative works on different terms, provided the original material is properly cited and the use is non-commercial. Please see: https://creativecommons.org/licenses/by-nc/4.0/